Subcutaneous DMPA (DMPA-SC) updates
As governments and partners work to ensure a wide variety of contraceptives are available in their country, self-injectable subcutaneous DMPA (DMPA-SC) can help address unmet need for family planning and increase access through a range of delivery channels.
Led by PATH in partnership with the Africa Resource Centre, Metrics for Management, Solina Centre for International Development and Research, and Health Systems Insight, the Advancing Injectable Markets for Sustainability (AIMS) project is dedicated to improving women’s choice and enduring access to injectable contraception. AIMS is creating a sustainable market for DMPA-SC and self-injection, ensuring balanced supply and demand with robust public- and private-sector access to contraceptive injectables for women living in low- and middle-income countries.
Sign up below to receive periodic updates on the global efforts of AIMS and its partners to expand contraceptive access and options. For more information, please visit the DMPA-SC Resource Library or email FPoptions@path.org.
DMPA-SC updates
